Hussman Strategic Advisors’s Globus Medical GMED Stock Holding History

Hussman Strategic Advisors’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-52,500	Closed	-$3.84M	–	246
2025 Q1	$3.84M	Buy	+52,500	New	+$4.34M	0.93%	15
2018 Q1	–	Sell	-50,000	Closed	-$2.06M	–	227
2017 Q4	$2.06M	Hold	50,000	–	–	0.59%	85
2017 Q3	$1.49M	Buy	+50,000	New	+$1.53M	0.36%	109
2016 Q2	–	Sell	-200,000	Closed	-$4.75M	–	189
2016 Q1	$4.75M	Buy	+200,000	New	+$4.89M	0.63%	62

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BAM

Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

HRCM

Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Hussman Strategic Advisors's GMED Position: Q2 2025 in Review

Hussman Strategic Advisors sold out of Globus Medical (GMED) in Q2 2025, closing a stake of 52,500 shares — an estimated $3.84M sold.

Hussman Strategic Advisors first reported a position in GMED in Q1 2016 and held it in 4 quarters. The position peaked at $4.75M in Q1 2016. 480 funds tracked by Wall St. Rank hold GMED as of Q2 2025.

Hussman Strategic Advisors reported no remaining Globus Medical position as of Q2 2025 after selling out during the quarter.
Hussman Strategic Advisors sold 52,500 Globus Medical shares in Q2 2025, an estimated $3.84M.
Hussman Strategic Advisors first reported a position in Globus Medical in Q1 2016 and held it in 4 quarters.
Hussman Strategic Advisors's Globus Medical position peaked at $4.75M in Q1 2016.
480 funds tracked by Wall St. Rank held Globus Medical as of Q2 2025.

Based on Hussman Strategic Advisors's 13F filing for Q2 2025, filed 5 Aug 2025.